EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interpretation of p53 immunohistochemical stain of TP53-mutated myeloid neoplasms

Nawroz Barwari, William Patrick Morrow, Joni K Evans, Nancy Rosenthal, Michael W Beaty, Eric Hsi, Giovanni Insuasti-Beltran, Danielle L V Maracaja

Frontiers in Oncology · 14.08.2026 · 16

DOI: 10.3389/fonc.2026.1916425 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 14.08.2026. Verfasst von Nawroz Barwari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Wake Forest University School of Medicine/Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC, United States. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wake Forest School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

TP53 mutational status ( TP53 ms) is prognostically important in myeloid neoplasms. Immunohistochemistry (IHC) of p53 has been used as a surrogate for TP53 mutations, with faster results than next-generation sequencing (NGS) and cytogenetic analysis. Given the challenges posed by heterogeneous p53 IHC expression, this study aims to evaluate the interobserver interpretation of p53 stain as a surrogate marker for TP53m .

Methods

Fifty-three bone marrow (BM) specimens previously diagnosed as myeloid neoplasms or nonneoplastic BM specimens with available concurrent TP53ms were evaluated. p53 IHC staining was performed on all 53 core biopsy or clot sections. TP53 mutation was found in 24 cases ( TP53 m). Twenty-nine specimens were TP53 wild-type and served as the control group. Six hematopathologists (HPs) blinded to the diagnosis and TP53 m independently scored the p53 staining pattern of the biopsies/clot sections for overall staining percentage (OSP) and staining intensity (dark staining percentage as a percentage of total cells (DCP)).

Results

The intraclass correlation was excellent for OSP (0.927) and good for DCP (0.848). For OSP, a cutoff of 30% resulted in sensitivity of 83.3%, specificity of 89.7%, PPV of 87.0%, and NPV of 86.7%. For DCP, a cutoff of 10% achieved sensitivity of 87.5%, specificity of 96.6%, PPV of 95.4%, and NPV of 90.3%. Additionally, DCP significantly correlated with the VAF of TP53 m (R = 0.469, p = 0.028).

Conclusion

High inter-rater reliability for OSP and DCP supports integrating p53 IHC into bone marrow evaluations for rapid TP53 m assessment. With superior specificity and predictive values, DCP proves to be a more reliable diagnostic marker for TP53 mutations. While this approach shows promise for myeloid neoplasms, further validation is needed to overcome challenges and expand its clinical utility for tailored treatment strategies.

Schlagwörter

Stichwörter der Autor:innen

TP53 mutation and expressionTP53-mutated myeloid neoplasmsdiagnostic accuracyinterobserver agreement assessmentp53 immunohistochemistry (p53 IHC)p53 protein expression

Autor:innen und Institutionen

  • Department of Pathology, Wake Forest University School of Medicine/Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC, United States.
  • Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
  • Department of Pathology, Duke University, Durham, NC, United States.

Förderung

  • Wake Forest School of Medicine

Zitieren

APA

Barwari, N., Morrow, W. P., Evans, J. K., Rosenthal, N., Beaty, M. W., Hsi, E., Insuasti-Beltran, G., & Maracaja, D. L. V. (2026). Interpretation of p53 immunohistochemical stain of TP53-mutated myeloid neoplasms. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1916425

Vancouver

Barwari N, Morrow WP, Evans JK, Rosenthal N, Beaty MW, Hsi E, et al. Interpretation of p53 immunohistochemical stain of TP53-mutated myeloid neoplasms. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1916425

BibTeX
@article{Barwari2026,
  author = {Barwari, Nawroz and Morrow, William Patrick and Evans, Joni K and Rosenthal, Nancy and Beaty, Michael W and Hsi, Eric and Insuasti-Beltran, Giovanni and Maracaja, Danielle L V},
  title = {Interpretation of p53 immunohistochemical stain of TP53-mutated myeloid neoplasms},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1916425}
}
Kostenlos starten →